Crescent Biopharma, Inc.
USD16.64
+1.59 (+10.56%)
CEO
Joshua T. Brumm
IPO Date
2014-01-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.64
Prev. Close
$15.05
Day Low
$15.63
Day High
$17.56
52W Low
$8.72
52W High
$27.41
Market Cap
$0.46B
Volume
0.77M
| $17.99 |
| 23 Jun 2026 | Scalzo Richard William | Chief Financial Officer | S-Sale | Disposed | 1,112 | $17.99 |
| 23 Jun 2026 | Bispham Barbara Harlin | See Remarks | S-Sale | Disposed | 1,218 | $17.99 |
| 23 Jun 2026 | Im Ellie Eunkyung | Chief Medical Officer | S-Sale | Disposed | 1,219 | $17.99 |
| 23 Jun 2026 | McNeill Jonathan | President and COO | S-Sale | Disposed | 20,549 | $17.99 |
| 23 Jun 2026 | Brumm Joshua T | director, officer: Chief Executive Officer | S-Sale | Disposed | 42,305 | $17.99 |
| 3 Jun 2026 | Violin Jonathan | director | A-Award | Acquired | 11,050 | $17.01 |
| 3 Jun 2026 | Lubner David Charles | director | A-Award | Acquired | 11,050 | $17.01 |
| 3 Jun 2026 | Balcom Alexandra | director | A-Award | Acquired | 11,050 | $17.01 |